Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interaction of Simmerafil and Alcohol in Healthy Males
NCT05316428Phase 1Completed
- Sponsor
- Vigonvita Life Sciences
- Start
- Feb 2022
- Primary completion
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of ASP-001 in erectile dysfunction (ED) (3 arms), sponsored by Vigonvita Life Sciences. Primary endpoints: Maximum change in blood pressure (systolic and diastolic) at 48 hours, Maximum change in pulse rate at 48 hours and 1 more. Started Feb 2022; status: completed.
02
Drugs
ASP-001
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT05316428.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05316428.